Antibe Therapeutics Stock Price on November 12, 2024
| ATBPF Stock | USD 0.22 0.00 0.00% |
If you're considering investing in Antibe Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Antibe Therapeutics stands at 0.22, as last reported on the 2nd of December, with the highest price reaching 0.22 and the lowest price hitting 0.22 during the day. We have found three technical indicators for Antibe Therapeutics, which you can use to evaluate the volatility of the firm.
Antibe Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Antibe |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ATBPF |
Based on monthly moving average Antibe Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Antibe Therapeutics by adding Antibe Therapeutics to a well-diversified portfolio.
Related Headline
Pmv Pharmaceuticals Headline on 12th of November 2024
Filed transaction by Pmv Pharmaceuticals Officer President And Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Antibe Therapeutics Valuation on November 12, 2024
It is possible to determine the worth of Antibe Therapeutics on a given historical date. On November 12, 2024 Antibe was worth 0.22 at the beginning of the trading date compared to the closed value of 0.22. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Antibe Therapeutics pink sheet. Still, in general, we apply an absolute valuation method to find Antibe Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Antibe Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Antibe Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.22 | 0.22 | 0.22 | 0.22 | 1.00 | |
11/12/2024 | 0.22 | 0.22 | 0.22 | 0.22 | 1.00 |
| 0.22 | 0.22 | 0.22 | 0.22 | 1.00 |
| Backtest Antibe Therapeutics | | | Antibe Therapeutics History | | | Antibe Therapeutics Valuation | Previous | Next |
Antibe Therapeutics Trading Date Momentum on November 12, 2024
| On November 13 2024 Antibe Therapeutics was traded for 0.22 at the closing time. The highest daily price throughout the period was 0.22 and the lowest price was 0.22 . There was no trading activity during the period 1.0. Lack of trading volume on 11/13/2024 did not affect price variability. The overall trading delta to current closing price is 0.00% . |
Antibe Therapeutics Fundamentals Correlations and Trends
By evaluating Antibe Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Antibe Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Antibe financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Antibe Therapeutics Pink Sheet history
Antibe Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Antibe is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Antibe Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Antibe Therapeutics stock prices may prove useful in developing a viable investing in Antibe Therapeutics
Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. Antibe Therapeutics Inc. was incorporated in 2009 and is headquartered in Toronto, Canada. Antibe Therapeutics is traded on OTC Exchange in the United States.
Antibe Therapeutics Pink Sheet Technical Analysis
Antibe Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Antibe Therapeutics Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
Antibe Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Antibe Therapeutics December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Antibe Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Antibe Therapeutics shares will generate the highest return on investment. By undertsting and applying Antibe Therapeutics pink sheet market strength indicators, traders can identify Antibe Therapeutics entry and exit signals to maximize returns
Complementary Tools for Antibe Pink Sheet analysis
When running Antibe Therapeutics' price analysis, check to measure Antibe Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Antibe Therapeutics is operating at the current time. Most of Antibe Therapeutics' value examination focuses on studying past and present price action to predict the probability of Antibe Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Antibe Therapeutics' price. Additionally, you may evaluate how the addition of Antibe Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |